Table 2.
Outcome of primary retinal detachment patients determined by COVID-19 status
| Totala | Pre-COVID-19 Group 1 |
During-COVID-19 Group 2 |
p | |
|---|---|---|---|---|
| Total | 1044 | 859 | 185 | – |
| Time between surgery and VA (days) | 134 (62 to 336) | 175 (71 to 372) | 70 (34 to 105) | < 0.001 |
| 3‑Month detachment rate (% yes) | 141 (13.5%) | 112 (13.0%) | 29 (15.7%) | 0.344 |
| Days to detachment surgery | 44 (27 to 72) | 47 (28 to 81) | 35 (23 to 62) | 0.156 |
| Pre-Op VA (LogMAR) | 0.48 (0.18 to 1.78) | 0.48 (0.18 to 1.78) | 0.60 (0.18 to 2.10) | 0.168 |
| Post-Op VA (LogMAR) | 0.30 (0.18 to 0.78) | 0.30 (0.18 to 0.78) | 0.48 (0.18 to 1.00) | 0.006 |
| LogMAR gain | 0.12 (−0.12 to 0.60) | 0.12 (−0.12 to 0.60) | 0.18 (−0.12 to 0.70) | 0.820 |
Continuous data are reported as median (interquartile range). The Mann–Whitney U test was used to compare continuous variables between groups. The chi-squared (> 2 groups) and Fisher’s exact test (2 groups) were otherwise used to compare nominal groups
Statistical significance in bold
a1044 patients included (266 patients excluded as not enough time elapsed for re-detachment rate to be calculated and for patients outside our catchment area)